Vol. 6 No. 01 (2022)
Review Article

Haematopoietic Stem Cell Transplantation

Full Article

PDF
Mahmud Hassan Arif
Assistant Professor Medicine, Chittagong medical college, Chittagong
Bio
Mohammad Moinuddin Chowdhury
Assistant Professor Medicine, Chittagong medical college, Chittagong
Bio
Enshad Ekram Ullah
Assistant Professor Medicine, Chittagong medical college, Chittagong
Bio
Mirza Nurul Karim
Assistant Professor Medicine, Chittagong medical college, Chittagong
Bio
Rajib Biswas
Assistant Professor Medicine, Chittagong medical college, Chittagong
Bio
Md. Abdullah Al Mamun
Assistant Professor , Department of Paediatrics, Rangamati Medical College, Rangamati
Bio

Find this Article on:

Abstract

Around 50,000 hematopatio stem cell transplants are done each year for the treatment of lymphoma, leukemia, immune deficiency diseases, and immunodefetocs, and hematopathies, and myelogenous and myelomen syndromes. Prior to transplantation, patients undergo myeloablative chemoradiation, after which they receive extensive “rescue” cell treatment a method of allogeneic HSCT is done by reinfusing the patient's own bloodderived stem cells, which are collected before transfusion. The stem cells used in allogeneic HSCT are human leukocyte antigens (HLA) balanced Allogeneic survival after transplantation depends on donor/patient pairing, the graft/recipient response, and the frequency of a donor leukemia impact. This article reviews the biology of stem cells, clinical efficacy of HSCT, transplantation procedures, and potential complications.

 

Downloads

Download data is not yet available.

Published 15-08-2022

Keywords

  • Haematopoietic Stem,
  • Cell Transplantation

How to Cite

1.
Arif MH, Chowdhury MM, Ullah EE, Karim MN, Biswas R, Mamun MAA. Haematopoietic Stem Cell Transplantation. Planet (Barisal) [Internet]. 2022 Aug. 15 [cited 2023 Feb. 4];6(01):302-1. Available from: https://bdjournals.org/index.php/planet/article/view/199